XENO DIAGNOSTICS

Xeno Diagnostics, LLC was established in 2007 with the purpose of providing products and services to aid in the use of pigs in transplantation and basic research. Xeno's success in establishing ELISA, PCR, cell culture assays, and antibody development led to clients requesting assistance with other cell-based assays utilizing other animal species. To meet those needs, Xeno expanded its focus to meet those needs as well as addressing unique requests from industry, academia, and startup companies. Additional cell based assays were developed to evaluate emerging technologies ranging from implantable tissues and biosynthetic materials to test compounds aimed at treating cancers, virii, and other diseases. Currently available assays include but are not limited to: Mixed Lymphocyte Reactions (MLR's), Cytotoxicity Assays (CDC/ADCC), Cytokine Release, Receptor Occupancy Assays, and Immunoglobulin Quantification... Xeno Diagnostics is proud to call itself the home of many talented and dynamic..

Also known as: Xeno Diagnostics, LLC

Primary location: Indianapolis United States